Press release
Neurofibromatosis Type 2 Treatment Market Size, Treatment Drugs, and Companies 2024
Neurofibromatosis Type 2 Treatment Market
DelveInsight's "Neurofibromatosis Type 2 Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Neurofibromatosis Type 2, historical and forecasted epidemiology as well as the Neurofibromatosis Type 2 market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Unlock detailed insights into the Neurofibromatosis Type 2 Market by downloading the comprehensive report from DelveInsight @ Neurofibromatosis Type 2 Treatment Market Size- https://www.delveinsight.com/sample-request/neurofibromatosis-2-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Neurofibromatosis Type 2 Market Report
• In September 2024:- AstraZeneca- A Phase III, Multicentre, International Study With a Parallel, Randomised, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET). A global study to demonstrate the effectiveness of selumetinib in participants with NF1 who have symptomatic, inoperable plexiform neurofibromas.
• In the 7MM, the total diagnosed prevalent cases of Neurofibromatosis type 2 (NF2) in 2023 were approximately 16,976. As per the estimates by DelveInsight, these cases are expected to increase at a substantial CAGR for the study period of 2020-2034.
• Assessments as per DelveInsight's analysts showed that in 2023 there were nearly 1,695 diagnosed prevalent cases of NF2 in children and adolescents and 8,897 cases in adults in the US. The overall cases are subjected to increase rapidly in the forecast period (2023-2034).
• The leading Neurofibromatosis Type 2 Companies such as Recursion Pharmaceuticals Inc., Betta Pharmaceuticals Co., Ltd., Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd, Novartis Pharmaceuticals, Genentech Inc., GlaxoSmithKline, AstraZeneca, and others.
• Promising Neurofibromatosis Type 2 Therapies such as REC-2282, HLX-1502, Vismodegib, Capivasertib, Brigatinib, Neratinib, and others
Gain a competitive edge in the Neurofibromatosis Type 2 Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Neurofibromatosis Type 2 Treatment Drugs- https://www.delveinsight.com/sample-request/neurofibromatosis-2-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neurofibromatosis Type 2 Epidemiology Segmentation in the 7MM
• Neurofibromatosis Type 2 Age-specific Diagnosed Prevalent Cases
• Total Neurofibromatosis Type 2 Diagnosed Prevalent Cases
• Neurofibromatosis Type 2 Tumor-specific Diagnosed Prevalent Cases
Neurofibromatosis Type 2 Market Insights
Neurofibromatosis Type 2 (NF2) presents with management dilemmas, as the current treatment options for NF2-related tumors provide only temporary benefits, and there are no FDA-approved pharmacologic therapies. The mainstay of management of NF2 is the surgical removal of symptomatic cranial and spinal tumors with regular monitoring. Tumors developing inside the brain and spinal cord can place a strain on the body and shorten life expectancy.
Discover key developments and opportunities in the Neurofibromatosis Type 2 Market. Click here to learn more from DelveInsight's latest report @ Neurofibromatosis Type 2 Market Size- https://www.delveinsight.com/sample-request/neurofibromatosis-2-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neurofibromatosis Type 2 Emerging Drugs Profile
• REC-2282: Recursion Pharmaceuticals Inc.
• VT3989: Vivace Therapeutics, Inc.
Neurofibromatosis Type 2 Therapeutics Market Landscape
The current market of NF2 is more or less dependent on supportive care such as Chemotherapy, corticosteroids, dexamethasone, others. At present, international studies have found that some drugs can effectively control or even reduce the size of tumors. Currently the use of drugs to treat NF2 has also gathered huge audience and active participation. Reduce tumor volume and control tumor growth through oral or intravenous injection of drugs has been observed with the use of Bevacizumab. Currently the Neurofibromatosis Type 2 therapeutics market has several key players involved in developing therapies. The emerging therapies are expected to create a significant positive shift in NF2 market size.
Download DelveInsight's Neurofibromatosis Type 2 Market report today and stay ahead in this rapidly evolving field. @ Neurofibromatosis Type 2 Clinical Trials- https://www.delveinsight.com/sample-request/neurofibromatosis-2-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Neurofibromatosis Type 2 Market Report
• Coverage- 7MM
• Neurofibromatosis Type 2 Companies- Recursion Pharmaceuticals Inc., Betta Pharmaceuticals Co., Ltd., Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd, Novartis Pharmaceuticals, Genentech Inc., GlaxoSmithKline, AstraZeneca, and others.
• Neurofibromatosis Type 2 Therapies- REC-2282, HLX-1502, Vismodegib, Capivasertib, Brigatinib, Neratinib, and others
• Neurofibromatosis Type 2 Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
• Neurofibromatosis Type 2 Unmet Needs, KOL's views, Analyst's views, Neurofibromatosis Type 2 Market Access and Reimbursement
Download the report to understand which factors are driving Neurofibromatosis Type 2 Market Trends @ Neurofibromatosis Type 2 Market Trends- https://www.delveinsight.com/sample-request/neurofibromatosis-2-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Neurofibromatosis Type 2
3. Competitive Intelligence Analysis for Neurofibromatosis Type 2
4. Neurofibromatosis Type 2: Market Overview at a Glance
5. Neurofibromatosis Type 2: Disease Background and Overview
6. Patient Journey
7. Neurofibromatosis Type 2 Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Neurofibromatosis Type 2 Unmet Needs
10. Key Endpoints of Neurofibromatosis Type 2 Treatment
11. Neurofibromatosis Type 2 Marketed Products
12. Neurofibromatosis Type 2 Emerging Therapies
13. Neurofibromatosis Type 2: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Neurofibromatosis Type 2
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2024
stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
pigment epithelial detachment market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Neuroendocrine Tumor Market- https://www.delveinsight.com/report-store/neuroendocrine-tumors-net-market
medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
keloid market- https://www.delveinsight.com/report-store/keloid-market
mouth neoplasms market- https://www.delveinsight.com/report-store/mouth-neoplasms-market
urinary retention market- https://www.delveinsight.com/report-store/urinary-retention-market
sglt2 inhibitors market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
urea cycle disorders market- https://www.delveinsight.com/report-store/urea-cycle-disorders-market
intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
embolotherapy market- https://www.delveinsight.com/report-store/embolotherapy-market
skin neoplasm market- https://www.delveinsight.com/report-store/skin-neoplasms-market
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
bone growth stimulators market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
meningococcal meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
endoscopic ultrasound market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
wilms tumor market- https://www.delveinsight.com/report-store/wilms-tumor-market
rhabdomyosarcoma market- https://www.delveinsight.com/report-store/rhabdomyosarcoma-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurofibromatosis Type 2 Treatment Market Size, Treatment Drugs, and Companies 2024 here
News-ID: 3691369 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Neurofibromatosis
Neurofibromatosis Market Dynamics Indicate Upward Trajectory Through 2032, Repor …
DelveInsight's "Neurofibromatosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Neurofibromatosis, historical and forecasted epidemiology as well as the Neurofibromatosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Neurofibromatosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Neurofibromatosis Market Forecast
https://www.delveinsight.com/sample-request/neurofibromatosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Neurofibromatosis…
Neurofibromatosis Type-1 Market Is Booming Worldwide - AstraZeneca, GlaxoSmithKl …
Neurofibromatosis Type-1 Market Insights
The Neurofibromatosis Type-1 Market is projected to reach USD 2.4 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).
Coherent Market Insights has published a new comprehensive analysis on the Neurofibromatosis Type-1 Market (2025-2032), focusing on critical transformations in the U.S. healthcare environment. This report highlights essential metrics including market size, revenue forecasts, CAGR, adoption trends, and regulatory drivers. Backed by clinical evidence…
Neurofibromatosis Treatment Market Size, Industry And Forecast To 2033
The new report published by The Business Research Company, titled Neurofibromatosis Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the neurofibromatosis treatment market size has grown rapidly in recent years. It will grow from $11.41 billion in 2023…
Neurofibromatosis Treatment Market Research Analysis, Application And Forecast T …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Neurofibromatosis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $21.58 billion In 2028 At…
Neurofibromatosis Type-2 Market Insight, Epidemiology and Market Forecast - 2027
Neurofibromatosis Type-2 Market research report is the new statistical data source added by Infinity Business Insights.
The genetic disease neurofibromatosis type 2 (NF2) is most often linked with bilateral vestibular schwannomas, also known as auditory neuromas. These benign (noncancerous) tumours develop on the balance and hearing nerves that go to the inner ear. Although benign, these tumours can cause hearing and balance issues. People with NF2 are also more likely…
Neurofibromatosis Treatment Market to Set Phenomenal Growth by 2023
Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue. These formed tumors may develop anywhere in the nervous system of the victim, which may include the brain, spinal cord and nerves. Neurofibromatosis is usually diagnosed in childhood or early adulthood. The tumors are noncancerous (benign) in most of the cases, but in some cases these tumors become cancerous…
